.bootstrap-dialog .modal-header.bootstrap-dialog-draggable{cursor:move} var krajeeDialogDefaults_71c625b2 = {"alert":{"type":"type-info","title":"Information","buttonLabel":" Ok"},"confirm":{"type":"type-warning","title":"Confirmation","btnOKClass":"btn-warning","btnOKLabel":" Ok","btnCancelLabel":" Cancel"},"prompt":{"draggable":false,"title":"Information","buttons":[{"label":"Cancel","icon":"glyphicon glyphicon-ban-circle"},{"label":"Ok","icon":"glyphicon glyphicon-ok","cssClass":"btn-primary"}],"closable":false},"dialog":{"draggable":true,"title":"Information","buttons":[{"label":"Cancel","icon":"glyphicon glyphicon-ban-circle"},{"label":"Ok","icon":"glyphicon glyphicon-ok","cssClass":"btn-primary"}]}}; var krajeeDialog_63269c26 = {"id":"w0"}; var krajeeDialog=new KrajeeDialog(true,krajeeDialog_63269c26,krajeeDialogDefaults_71c625b2);
1. Parliamentary panel bats for laws to counter bioterrorism (GS-3)
UPSC Syllabus : Security
2. COVID19 is world’s biggest challenge: PM (GS-2)
UPSC Syllabus : Bilateral, regional and global groupings and agreements involving India
3. Odisha tribe sees rise in migration (GS-2)
UPSC Syllabus : Indian Society
4. U.S., Taiwan step up economic partnership (GS-2)
UPSC Syllabus : International relations
5. India to double oil refining capacity in five years, says PM (GS-2)
UPSC Syllabus : Energy
6. How kala-azar was eliminated from a highly endemic district in Bihar (GS-2)
UPSC Syllabus : Health
7. Twice hit by climate change (GS-2)
UPSC Syllabus : Science and Technology
8. Ethics of denying COVID-19 vaccine to placebo group (GS-3)
UPSC Syllabus : Science and Technology
9. A successful solution to the ‘slash and burn’ problem (GS-2)
UPSC Syllabus : Science and Technology
10. Why did India stay out of the RCEP deal? : (GS-3)
UPSC Syllabus : Bilateral, regional and global groupings and agreements affecting India’s interests
11. Moratorium on banks (GS-2)
UPSC Syllabus : Indian Economy: Planning
12. A host of vaccines and the fight COVID-19 (GS-4)
UPSC Syllabus : Ethics-Ethics in clinical trials and drug development
Current Affairs
Monthly Magazine